Komori
Zeria Pharmaceutical (4559) · PolicyAdvanced

Management of Material Issues under the Sustainability Basic Policy

First written in FY2023. 3 of 4 entries say "Advanced", first in FY2024. Latest entry: FY2026.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2024 – FY20262023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Management of Material Issues and Board Oversight Framework for Sustainability ManagementA theme 878 companies write about · 0 as a headwind · 891 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 897 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「We identified 10 materialities as key issues requiring priority attention among sustainability-related issues. …This year's analysis covered ゼリア新薬工業 on a standalone basis, identifying risks and opportunities expected to have future impacts and estimating their financial impacts in fiscal 2030 and fiscal 2050.」

    Ten sustainability-related key issues were identified as materialities, followed by scenario analysis of climate change and estimates of its financial impact in fiscal 2030 and fiscal 2050.
  2. FY2025AdvancedAnnual report

    「In April 2024, we established the Sustainability Committee to promote sustainability activities and strengthen the management structure. The committee is chaired by a director responsible for the Administrative Headquarters, with the heads of related departments and plant managers serving as members. As a rule, the committee discusses sustainability-related initiatives and important matters twice a year and reports on its activities and progress to the Board of Directors once a year. In addition, a working group was established as a subordinate body of the Sustainability Committee to facilitate more specialized discussions and practical initiatives.」

    The frequency of Sustainability Committee meetings, reporting to the Board of Directors and establishment of a working group were specified, representing progress in the management structure.
  3. FY2024AdvancedAnnual report

    「In April 2024, we established the Sustainability Committee to promote sustainability activities and strengthen the management structure. The committee is chaired by a director responsible for the Administrative Headquarters, with the heads of related departments and plant managers serving as members.」

    The Sustainability Committee was established in April 2024 to promote sustainability activities and strengthen the management structure.
  4. FY2023First statedAnnual report

    「Our Group is addressing various sustainability-related issues, including social and environmental issues, as key management priorities. In fiscal 2021, we formulated the Basic Sustainability Policy of ゼリア新薬工業 and have been advancing specific initiatives addressing social and environmental issues.」

    Sustainability was positioned as a key management priority, and initiatives based on the basic policy formulated in fiscal 2021 were disclosed for the first time as a standalone theme.
Moved together

"Stable and Consistent Dividends and Strengthening Retained Earnings" moved the same way as this thread, in the same document, in 3 of its 4 moves.

333333★123456
  1. ★This thread
  2. 1Stable and Consistent Dividends and Strengthening Retained Earnings3×
  3. 2Strengthening the Foundation as a Global Company3×
  4. 3Growth of the Prescription Pharmaceutical Business Driven by Asacol, Acofide, and Entocort3×
  5. 4Enhancing the New Drug Pipeline and Consumer Healthcare Products3×
  6. 5Progress in Clinical Trials and Regulatory Filings for Multiple Products3×
  7. 6Expansion of overseas sales3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zeria Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.